Introduction
Human papillomavirus (HPV) can cause a number of anogenital and oropharyngeal cancers in men and women. 1, 2 To prevent morbidity and mortality, three vaccines have been licensed and recommended for use. 3, 4 Currently, over 80 countries have implemented national HPV vaccination programs. 1, 5, 6 In Canada, provinces and territories have implemented publicly funded school-based HPV vaccine programs. All Canadian jurisdictions implemented programs for girls, from 2007-2010. 7, 8 As of 2018, all jurisdictions also offer programs for boys in schools; 9 however, the roll out of these programs (since 2013) has been staggered and HPV vaccination rates in Canada remain suboptimal. 3, 8, 10 Because HPV vaccination targets children, 3 parental acceptance is critical to ensuring uptake. Previous research has indicated common themes associated with uptake, such as the importance of parents believing in the benefits of vaccination and perceiving few barriers. 11, 12 Unsurprisingly, parents are less likely to vaccinate their children if they are not aware of, or do not know enough about, HPV vaccination. Parents are also less likely to vaccinate their child if they believe that HPV vaccination can cause harm, or that vaccination is not accessible or affordable. 13 Furthermore, positive attitudes towards vaccines in general are related to HPV vaccine acceptance. 14, 15 Notably, a strong health care provider (HCP) recommendation significantly improves parental vaccine acceptance. 4, 11, 16 Other social influences, including by a partner, family, friends, or online social network, can also influence parents' decision. 13, [16] [17] [18] It is likely that these factors have varying impact on parents depending on where they are in the decision-making process, which is obscured in much previous research investigating vaccination as a binary outcome (vaccinated or not). Literature on vaccine hesitancy highlights many reasons a parent may delay or refuse vaccination for their child. 19 A theoretical stage-based model, the Precaution Adoption Process Model (PAPM), allows for a nuanced examination of which modifying factors and individual health beliefs are important for each stage of decisionmaking ( Figure 1 ). [20] [21] [22] The PAPM identifies six stages involved in making a health decision and clarifies what factors lead individuals to move from one health behaviour decision-making stage to the next 23 . A stage-based understanding of HPV vaccine decision-making is important for identifying the psychosocial correlates for each stage and how to best intervene for parents at different stages. Nevertheless, few studies have examined the stages of HPV vaccine decision-making in college students and parents of only boys, 16, [24] [25] [26] and no study has compared the stages of decision-making of parents of girls to parents of boys. Previous studies have found that college students and parents of boys were in the earliest stages of HPV vaccine decisionmaking. 16, [24] [25] [26] Given HPV vaccine programs and policies have differentially targeted boys and girls, it is important to examine differences in decision-making stage between parents of girls and boys.
This study will identify and compare parents' stage of decision-making by gender for their school-aged daughters and sons, examine differences in parents' HPV vaccine knowledge and attitudes by PAPM stage, and investigate the psychosocial correlates of parents' PAPM stages.
Methods

Survey design and participants
Details of the methodology are presented in the protocol paper. 20 This study used a crosssectional design to collect self-reported online survey data from a national sample of Canadian parents. Data presented here were part of a larger two-wave protocol and were collected from August 17 to September 11, 2016 (i.e. Time one). All Canadian jurisdictions at this time had publicly funded, school-based HPV vaccination programs for girls but only three provinces (i.e. Alberta, Prince Edward Island, and Nova Scotia) had programs for boys.
This study targeted parents and/or guardians (hereafter referred to as parents) of [9] [10] [11] [12] [13] [14] [15] [16] year-old boys and girls. Parents with more than one child were asked to answer the questionnaire in reference to the child who had the most recent birthday to ensure randomization. The online survey was offered in English and French (i.e. Canada's two official languages). Participants were recruited using, Leger 
Measures
The dependent variable was parents' PAPM stage, which categorizes parents' stage of decision-making regarding HPV vaccination into six stages (Figure 1 ). 21 Potential psychosocial predictors of HPV vaccine decision-making included sociodemographics, HCP recommendation, as well as validated scales to assess HPV and HPV vaccine knowledge, HPV vaccine attitudes, and general vaccine attitudes. HCP recommendation was assessed by asking parents, 'did a health care provider (e.g. a doctor, pediatrician, or nurse) recommend that [child's name] receive the HPV vaccine within the last 12 months?'. Parents were only administered this question if they had answered affirmatively that they had seen a HCP and discussed their child receiving the HPV vaccine with a HCP.
Two validated scales were used to measure parents' knowledge of HPV and HPV vaccine. 28, 29 The 23-item HPV General Knowledge Scale (α=.94) and the 11-item HPV Vaccine Knowledge (VK) Scale (α=.88) (Appendix 1). To each item, respondents answered 'true', 'false', or 'don't know', for which a total score was calculated based on correct answers (higher scores indicate greater knowledge on both scales).
HPV vaccine attitudes were assessed using constructs from the Health Belief Model (HBM) including perceived benefits of, and barriers to, HPV vaccination; perceived severity of, and susceptibility to, HPV infection and disease; external influences prompting HPV vaccine uptake (i.e. cues to action), and the ability to exert change (i.e. self-efficacy). Sub-scales from the psychometrically validated HPV vaccination Attitudes and Beliefs Scale (HABS) were used to evaluate constructs from the HBM using a 7-point Likert-type rating scale ranging from 1 (strongly disagree) to 7 (strongly agree). 29 Sub-scales were evaluated for internal consistency using Cronbach's α. HBM constructs, assessed using HABS subscales, included perceived susceptibility of child to HPV and its consequences (3 items, α=.92), perceived severity of HPV and its consequence (3 items, α=.84), perceived benefits of HPV vaccine (10 items, α=.94), perceived barriers to HPV vaccine (6 items to measure harms, α=.93; 4 items to measure accessibility, α=.79; and 3 items to measure affordability, α=.87), cues to action (8 items, α=.91), and self-efficacy (4 items α=.89) (Appendix 1). 1 General vaccine attitudes were assessed using two psychometrically validated scales: the Vaccine Conspiracy Beliefs Scale (VCBS) and the Vaccine Hesitancy Scale (VHS). 14, 15 The VCBS has seven items assessed on a 7-point Likert-type rating scale (α=.95). The VHS was developed by the World Health Organization Sage Working Group on Vaccine Hesitancy, 30 and psychometrically validated by our research group. 15 The VHS was found to have two underlying factors (i.e. 'lack of confidence', α=.92; and 'risks', α=.64) and items are assessed on a 5-point Likert-type rating scale (Appendix 1).
Analysis
This study reports parents' HPV vaccine decision-making in percentages based on the six PAPM stages. For assessing significant differences in PAPM stage based on child's gender, a chi-square test was used.
To examine differences between reported vaccine knowledge and attitudes by PAPM stage, one-way ANOVA and Tukey Honest Significant Difference (HSD) post-hoc tests were conducted.
Multinomial logistic regression analyses were used to calculate the odds ratios of being in one of the first five PAPM stages compared to PAPM stage 6 (i.e. vaccinated, reference category). PAPM stage was the dependent variable. First, we conducted bivariate multinomial logistic regression analyses and estimated the associations for each independent variable individually. Subsequently, we performed multivariate multinomial logistic regression analyses by including 14 independent variables in a single model. In order to select variables that would ensure the most parsimonious and theory-driven multivariate model, variables were included based on attitudes predicted to be associated with behavioural change (according to the HBM) and significant modifying factors in the literature (see Figure 1 ). 16, 31 Odds ratios and 95% confidence intervals (CI) were calculated. To assess multicollinearity of the multivariate multinomial logistic regression models, the Variation Inflation Factor (VIF) was calculated for all predictors. Model fit diagnostics were reported based on following criteria: (a) Cox-Snell R 2 , Statistical analyses were performed using IBM SPSS V.23 and R 3.3.2.
Results
Sample Demographics
A total of 4,606 parents completed the survey. The response rate, calculated based on completion by participants who initiated the questionnaire (N=6,789) was 67.9%. Overall, 827 (18.0%) participants were excluded as these participants were detected to be inattentive or unmotivated respondents based on data cleaning (i.e. the use of two bogus items and index of psychometric synonyms). 20 Sociodemographic characteristics for the final sample (N=3,779) are presented in Table 1 . At the time of data collection, only 7% were parents of boys living in provinces where there was a publicly funded HPV vaccine program for boys available (n = 252) and fewer still would have been eligible for the program depending upon their child's age. Table 2 shows the numbers of parents of boys and parents of girls across the six PAPM stages. HPV vaccine uptake of Canadian children was low, with only 801 (41.0%) parents of girls reporting that their daughters were vaccinated and only 160 (8.8%) parents of boys reporting that their sons were vaccinated. There was a significant and large association between child's gender and PAPM stage of decision making (χ 2 (5)=735.25, p<.001, φc=.44) with parents of boys more likely to be in earlier stages. 32
Identifying Canadian parents' stage of decision-making by child's gender
Comparison of knowledge and attitudes for HPV vaccine PAPM stages
One-way ANOVA found that there was a significant effect of PAPM stage on all vaccine knowledge and attitude scales ( Table 3 ). The greatest effect sizes were for cues to action, benefits, and barriers-harms.
Post hoc analyses found that knowledge (both HPV vaccine knowledge and HPV general knowledge) was significantly lower for PAPM stages 1-3 (unaware, unengaged, and undecided) compared to later PAPM stages. In addition, parents who were unaware reported significantly lower perceived vaccine affordability compared to parents who were unengaged and undecided, while parents who were unaware and unengaged reported significantly lower perceived harms and VHS-risk compared to parents who were undecided.
Parents who decided not to vaccinate (Stage 4) significantly differed from all other PAPM stages on all scales except barriers-not accessible, self-efficacy, and knowledge scales (VK and GK); however, on these four scales, parents who decided not to vaccinate responded similarly to parents who decided to vaccinate or already vaccinated their child (Stages 5 and 6).
Parents who decided to vaccinate their child (Stage 5) reported significantly higher perceived benefits, greater perceived barriers of accessibility and affordability, and fewer cues to action compared to those who already vaccinated their child (Stage 6).
Examination of correlates of PAPM stage
The bivariate and multivariate multinomial logistic regression analyses of parents' PAPM stage can be found in Tables 4 and 5 
Bivariate multinomial logistic regression
Parents of daughters, older children, and parents with a HCP recommendation had decreased odds of being in any earlier PAPM stage as compared to the last PAPM stage (i.e. vaccinated). Higher HPV vaccine knowledge was significantly associated with decreased odds of being unaware, unengaged, undecided, or decided to vaccinate.
Parents who had decided not to vaccinate their child had significantly stronger vaccine conspiracy beliefs (OR=3.10; 95% CI 2.78;3.46), lack of confidence in vaccines (OR=9.21; 95% CI 7.50;11.31), and higher perception of vaccine risks (OR=5.19; 95% CI 4.38;6.16) compared to parents who vaccinated their child.
Parents living in provinces with HPV vaccination programs for boys had significantly lower odds of being unaware (OR=0.34; 95% CI 0.24;0.48), unengaged (OR=0.49; 95% CI 0.34;0.70), or undecided (OR=0.50; 95% CI 0.37;0.67). Further analysis by child's gender indicated that this effect was not significant in the model examining parents of girls; however, parents of boys living in provinces with HPV vaccine funding for boys had significantly lower odds of being in any earlier PAPM stage compared to vaccinated (Tables B4 and B7) .
Multivariate multinomial logistic regression
Parents of daughters and older children had significantly decreased odds of reporting that their child was in any earlier PAPM stage compared to vaccinated. Parents answering the survey Compared to those who vaccinated their child, parents in all other stages had significantly increased odds of reporting greater barriers (including affordability, accessibility, and perceived harms). However, perceived accessibility of parents who vaccinated their children did not differ significantly with parents who were undecided, decided not to vaccinate their child, or decided to vaccinate their child. Of note, parents who had a higher score on perceived harms had higher odds of being in Stage 4 (decided not to vaccinate) (AOR=3.50; 95% CI 2.85;4.28). Greater perceived influence of others (cues to action) was associated with lower odds of being in any of the earlier stages (compared to vaccinated) (AOR range of 0.20 to 0.51).
Discussion
This study examined six distinct stages of HPV vaccine decision-making using the PAPM framework in a national survey of Canadian parents of 9-16 year-old boys and girls. Only 41.0% of girls and 8.8% of boys were in the final PAPM stage (Stage 6-Vaccinated). This is a lower proportion of vaccinated children than reported by other Canadian studies, 3, 33 which may be due to this study's design, which included data from jurisdictions without male HPV vaccination programs during data collection, relied on parental report of vaccination status, and evaluated a larger age range of children (including children before they were offered the HPV vaccine in funded school-based programs).
In a 2014 study using the PAPM to examine Canadian parents of boys, the majority of parents were unaware of HPV vaccination for their sons (Stage 1, 57.0%), while exceptionally few had decided to vaccinate their son (Stage 5, 5.0%) or had sons who had received the HPV vaccine (Stage 6, 1.1%). 16 Data from the present study indicates that two years later and with two additional Canadian jurisdictions with male HPV vaccine programs (Alberta and Nova Scotia), fewer parents were unaware (25.6%), and more parents had decided to vaccinate (19.1%) or already vaccinated (8.8%) their son ( Table 2) . By comparison, a survey of parents of boys conducted around the same time in the UK (when there was no funded program for boys) found that 46.8% were unaware. 34 This emphasizes the importance of publicly funded vaccine programs and the associated educational campaigns in increasing awareness and uptake. [35] [36] [37] Two further studies have used the PAPM to evaluate HPV vaccine decision-making. 26, 38 Though these studies were conducted in college students, both found males to be overwhelmingly unaware or unengaged (90% or 85.7%, respectively), 26, 38 and Barnard et al. also found females to be predominantly in these stages (62.9%). 38 The present study was unique in evaluating PAPM stages for both parents of girls and boys. The literature has primarily focused on parents of girls, 35, [37] [38] [39] [40] [41] [42] [43] [44] with none using the PAPM.
We found a significant association between child's gender and PAPM stage of decision-making, with parents of boys more likely to be in earlier PAPM stages, a finding similar to results from other studies. 35, 37, [39] [40] [41] Multinomial analyses highlighted some important correlates across all PAPM stages as well as some correlates that are particularly important for specific stages. Overall, this study found that parents of daughters (compared to sons), of older children, and parents with a HCP recommendation had decreased odds of being in any earlier PAPM stage as compared to the last PAPM stage (i.e. vaccinated). The importance of a HCP recommendation in making the decision regarding HPV vaccination is a well-established finding. 11, 12, 16, 35, 37, 41, 45 This study contributes to the literature by highlighting that a HCP recommendation is a significant and important differential factor between parents who are 'hesitant' (unengaged, undecided, and decided not; Stages 2-4) and 'acceptors' (decided to vaccinate and vaccinated; Stages 5-6), but not a significant differential factors between acceptor groups (Stages 5 and 6). This suggests that while a HCP recommendation may increase the likelihood that a parent accepts HPV vaccination; a HCP recommendation alone may not be sufficient to move parents from deciding to vaccinate their child (Stage 5) to having vaccinated their child (Stage 6).
The relationship between knowledge and uptake has previously yielded mixed results (as high and low knowledge have been associated with vaccination). 12, 46 Application of the PAPM model shows that low HPV vaccine knowledge is an important correlate of early stages of decision-making (as compared to vaccinated). Interestingly, in the multivariate analysis parents who had decided not to vaccinate their child had significantly higher HPV vaccine knowledge than parents who vaccinated their child. Accordingly, education interventions alone may not be sufficient for HPV vaccination.
In line with previous research, this study found perceived benefits, barriers-harms, and cues to action were key correlates of PAPM stage. 12 Previous research using a binary outcome has reported mixed findings regarding the relationship between HPV vaccination with perceived severity and susceptibility of HPV infection and associated disease. 12, 31 By using a nuanced framework of decision-making, this study highlights that, when taking all other variables into account, susceptibility and severity were not significant correlates of earlier PAPM stages except for the 'decided not to vaccinate' stage (Stage 4). Future research should use these findings to investigate theoretically informed interventions to specifically target subsets of the population (by child's gender and decision-making stage), with particular attention towards addressing knowledge gaps, perceived barriers, and concerns of parents.
Interestingly, parents of boys (but not parents of girls) living in provinces with HPV vaccination programs for boys had significantly lower odds of being in early PAPM stages, emphasizing the importance of publicly funded HPV vaccine programs for boys.
Study strengths and limitations
This study is unique in examining and comparing HPV vaccine decision-making in Canadian parents of boys and girls using two well-established theoretical frameworks (i.e. the HBM and the PAPM), which captures decision-making in a nuanced and precise way. This is the first study to use the PAPM to evaluate HPV vaccine decision-making in parents of girls and boys. Strengths of the study also include a large sample size, data cleaning techniques that eliminated careless responders, and a nationally representative sample. 20 This study's questionnaire benefited from the use of intelligent programming to personalize survey items, administration in either English or French, avoiding any missing data, the use of psychometrically validated scales, and the randomization of items within scales to reduce the possibility of an order effect. 20 This study is not without limitations. The cross-sectional design makes it impossible to determine causality. Although we had a reasonable response rate (67.9%), there remains the potential that there were similarities between non-responders that could influence the representativeness of the sample. Furthermore, although the sample was generally representative of the Canadian population, it was slightly wealthier, more educated, and White (as compared to the 2016 Census). 47 This study was also not able to recruit many participants living in Canada's territories, due to constraints in Leger's panel. Future research is needed to replicate this study's conceptual framework and findings to specifically investigate HPV vaccination in disadvantaged populations, as well as in other countries or in cross-country comparisons.
It is also possible that the measurement of HCP recommendation in this study overlooked parents who were recommended the vaccine by a HCP but had not seen or discussed the HPV vaccine with a HCP (e.g. via a letter that was sent home). Moreover, the scope of variables assessed is limited, there are other familial, sociological, environmental, and communication factors that were not included. Specifically, future research should consider the impact of having an older child who was eligible for, or received, the HPV vaccine. Future research should also further examine the impact of publicly funded HPV vaccination programs on parents' decisionmaking.
Conclusions
HPV vaccination remains low in Canada. Using a stage-based model of decision-making, this study found that only a quarter of parents were in the final PAPM stage. Parents of daughters, older children, and those with a HCP recommendation had decreased odds of being in any earlier PAPM stage. Individual health beliefs as well as cues to action were key correlates of PAPM stage overall; however, the combinations and importance of correlates varied by PAPM stage and child's gender. These findings indicate that it may be important for future interventions to target and tailor health messaging for different groups depending on their stage of decisionmaking.
Figure 1. An integrated conceptual framework of HPV vaccination
Note. The PAPM, as applied to HPV vaccination, identifies individuals along six stages of decision-making: 1) unaware of the vaccine ("I was unaware that the HPV vaccine could be given to CHILD*"); 2) unengaged in the decision to vaccinate their child ("I have never thought about vaccinating CHILD* against HPV"); 3) undecided about whether to vaccinate their child ("I am undecided about vaccinating CHILD* against HPV"); 4) decided not to act (i.e. decided not to vaccinate their child, "I have decided I DO NOT want to vaccinate CHILD* against HPV"); 5) decided to act (i.e. decided to vaccinate their child, "I have decided I DO want to vaccinate CHILD* against HPV"); and 6) acted (i.e. vaccinated their child, "CHILD* has already received the HPV vaccine"). *To increase the personalization of this questionnaire, intelligent programming allowed for each question with "CHILD" to specifically include their child's name. The reference category for PAPM stage is 'Stage 6-Vaccinated' (n = 961). Cox-Snell R 2 = 0.72. Cragg Uhler R 2 = 0.74. McFadden R 2 = 0.37. (reference) = reference category. AOR = adjusted odds ratio. 95% CI = 95% confidence interval. HCP = health care provider.
